RecruitingNot ApplicableNCT05860894

Post Intensive Care Unit Atrial Fibrillation


Sponsor

Centre Hospitalier Universitaire de Besancon

Enrollment

150 participants

Start Date

Sep 19, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Atrial fibrillation (AF) is a common heart rhythm disorder in the intensive care unit (ICU). It can be precipitated by multiple factors but it is unclear whether AF persists after discharge from the ICU, and long term. This study will investigate whether AF recurs up to one year after ICU discharge.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Age \>18 years
  • New onset atrial fibrillation diagnosed in the ICU (12 lead ECG or documented episode of atrial fibrillation lasting at least 30 seconds)
  • Patient hospitalized in the ICU with at least one of the following two criteria:
  • orotracheal intubation for mechanical ventilation
  • AND/OR treatment with amines (vasopressors or inotropic agents)
  • Written informed consent
  • Patient affiliated to a social security regime (or beneficiary thereof)

Exclusion Criteria6

  • Documented history of atrial fibrillation
  • patients admitted to the ICU after cardiothoracic surgery
  • Patients with life expectancy \<12 months
  • Patients under legal or judicial protection
  • Patients with no social security coverage
  • Patients within the exclusion period of another clinical trial

Interventions

DEVICEImplantable ECG holter device (Biomonitor3, Biotronik)

Subcutaneous implantation of ECG holder device to monitor ECG


Locations(1)

Centre Hospitalier Universitaire de Besancon

Besançon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05860894


Related Trials